Soft Tissue Biologics Market Analysis: Emerging Technologies and Forecast
The Soft Tissue Biologics Market is becoming increasingly important to the global regenerative medicine and advanced wound-care industries. The market is expected to rise to approximately USD 10.6 billion by 2032 from USD 4.36 billion in 2024, reflecting an estimated CAGR of 11.75%. Allogeneic biologics are expected to hold a leading position among source categories. The report attributes this...
0 Comments 0 Shares 81 Views 0 Reviews